VTC Hosts TB/HIV R01 Meeting
May 8, 2023
Vanderbilt Tuberculosis Center recently hosted a meeting of researchers involved in our TB/HIV grant "Predictors of treatment toxicity, failure, and relapse in HIV-related tuberculosis" (NIH R01AI120790-04). The event, which took place on April 26th and 27th, included presentations on the results and findings of each working group, breakout sessions, and discussions on future steps to be taken and larger goals of the research.
VUMC lands Grant to build top-line Biosafety Facility
October 3, 2022
https://news.vumc.org/2022/09/29/vumc-lands-grant-to-build-top-line-biosafety-facility/
Vanderbilt University Medical Center has been awarded a nearly $8 million grant from the National Institutes of Health to construct a state-of-the-art BioSafety Level 3 (BSL3) facility for research involving the COVID-19 virus, anthrax and other dangerous microorganisms. When the renovation of about 3,500 square feet of existing space is completed, the facility will include three BSL3 suites with separate entrances and seven procedure rooms capable of securely containing multiple organisms at the second-highest biosafety level.
VUMC investigators attend RePORT-International Annual Meeting
September 15, 2022
VUMC investigators and staff, Timothy Sterling, Yuri van der Heijden, Stephany Duda, Marina Figueiredo, Fernanda Mauri, Megan Turner, and Austin Katona; attended the annual RePORT International meeting that was held in Cape Town, South Africa, September 7 and 8, 2022. The meeting included all seven regions of RePORT: Brazil, China, South Africa, South Korea, India, Indonesia, and the Philippines. It was a successful meeting full of presentations and collaborative discussions.
WHO Global TB Report was released!
October 28, 2021
Each year, the WHO Global TB Report provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease, at global, regional and country levels. This is done in the context of global TB commitments, strategies and targets.
University of Washington's 4th Annual Advanced TB Research Training Course - Sept 13-17, 2021
July 14, 2021
The University of Washington's Department of Global Health and the Tuberculosis Research and Training Center (TRTC) are accepting applications for the 4th Annual Advanced TB Research Training Course. The course will be held as a Virtual Only course September 13 - 17, 2021.
Publication Announcement: “Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis"
May 10, 2021
The U.S. Centers for Disease Control and Prevention (CDC) Tuberculosis Trials Consortium (TBTC), together with collaborators from the National Institutes of Health’s (NIH) AIDS Clinical Trial Group (ACTG), is pleased to announce the publication of “Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis" in the New England Journal of Medicine.
Vanderbilt TB Center FY 2020 Annual Report has been released!
January 25, 2021
The TB Center Annual Report from FY 2020 has now been published, detailing Center activities, research, and funding for the 2020 fiscal year. See the link below to download the full report. We look forward to continued progress toward our research goals in the current year.
Heather Ewing presents MPH Thesis on TB and Stigma
March 5, 2018
Heather Ewing, MA(c), MPH(c), presented her MPH thesis on Friday, March 2, titled "Knowledge of Tuberculosis is Associated with Greater Expression of Stigma in Brazil". This project stemmed from a Vanderbilt Trans-Institutional Program grant (TIPs), which focused on healthcare in Brazil.
Successful RePORT-International Annual Meeting in Rio de Janeiro, Brazil
September 15, 2017
The Regional Prospective Observational Research for Tuberculosis (RePORT)- International Annual Meeting was held Tuesday, September 12 through Wednesday, September 13, 2017 in Rio de Janeiro, Brazil. RePORT-International is now composed of 5 regions: Brazil, China, India, Indonesia, and South Africa.